Tue, 07 Nov 2017 11:25:00 +0100
Xavant Technology set to Disrupt Neuropathic Pain Treatment in the UK
Trial study at St Thomas’s Pain Management Centre shows dramatic effectiveness to treat chronic intractable pain PRETORIA, South Africa, 27 March, 2018 -- Xavant Technology (Pty) Ltd today announced the launch of their Stimpod NMS460 in the U.K. The Stimpod NMS460, a non-invasive neuromodulation device, is focused on the symptomatic relief and management of neuropathic pain as well as an adjunctive treatment in the management of post-surgical pain, post-traumatic acute pain problems, and an adjunct...
Thu, 07 Apr 2016 09:24:00 +0100
Chronic Conditions Such As Diabetes Can Pose A Greater Risk To Some Business Travellers Than Infectious Diseases
International SOS provides travel advice on World Diabetes DayTrevose, November 7 2017 – In advance of World Diabetes Day, on November 14, International SOS highlights the importance for travellers to manage their diabetes. Due to a range of factors inherent in travel, the ongoing medical management of mobile workers with chronic diseases such as diabetes may be disrupted. Failing to effectively manage chronic conditions can pose a greater risk to some traveling business executives than...
Online conversations about diabetes: 34% are to discuss medication and diet while only 4.8% involve exercise
These statistics have been taken from the European E-patient Report 2015 – an exhaustive study into the impact an illness has on an individual’s day-to-day activities and social life.Surprisingly, while exercise is considered to be a key component of diabetes management (along with medication and diet), it doesn’t feature very highly in online conversations - which highlights the need to raise awareness in this particular area.London (United Kingdom) | Madrid (Spain), 7th April 2016 –...
view page: 62